BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21091088)

  • 1. GAD1 is a biomarker for benign and malignant prostatic tissue.
    Jaraj SJ; Augsten M; Häggarth L; Wester K; Pontén F; Ostman A; Egevad L
    Scand J Urol Nephrol; 2011 Feb; 45(1):39-45. PubMed ID: 21091088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation study of expression levels of prostate-specific membrane antigen and prostate-specific antigen with Gleason score of prostate carcinoma].
    Ren JQ; Chen ZQ; Zheng L; Chen Q; Li H; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):735-8. PubMed ID: 15733392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
    Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R
    Tunis Med; 2013 Jul; 91(7):458-63. PubMed ID: 24008878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R
    J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSMA/PSA ratio evaluated by immunohistochemistry may improve diagnosis of prostate cancer.
    Jemaa AB; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
    J Immunoassay Immunochem; 2014; 35(1):48-59. PubMed ID: 24063616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.
    Bravaccini S; Puccetti M; Bocchini M; Ravaioli S; Celli M; Scarpi E; De Giorgi U; Tumedei MM; Raulli G; Cardinale L; Paganelli G
    Sci Rep; 2018 Mar; 8(1):4254. PubMed ID: 29523813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.
    Mhawech-Fauceglia P; Zhang S; Terracciano L; Sauter G; Chadhuri A; Herrmann FR; Penetrante R
    Histopathology; 2007 Mar; 50(4):472-83. PubMed ID: 17448023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10 ng/mL.
    Birtle AJ; Freeman A; Masters JR; Payne HA; Harland SJ;
    BJU Int; 2005 Aug; 96(3):303-7. PubMed ID: 16042718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma.
    Bernacki KD; Fields KL; Roh MH
    Diagn Cytopathol; 2014 Jul; 42(7):570-5. PubMed ID: 24273068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma.
    Jia L; Jiang Y; Michael CW
    Diagn Cytopathol; 2017 Nov; 45(11):998-1004. PubMed ID: 28888085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiling identifies an interaction of IL-6 and IL-1α to drive PSMA-PSA prostate clones.
    Jemaa AB; Bouraoui Y; Rais NB; Nouira Y; Oueslati R
    Immunobiology; 2016 Dec; 221(12):1424-1431. PubMed ID: 27451139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade.
    Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R
    Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSMA expression is highly homogenous in primary prostate cancer.
    Tsourlakis MC; Klein F; Kluth M; Quaas A; Graefen M; Haese A; Simon R; Sauter G; Schlomm T; Minner S
    Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):449-55. PubMed ID: 26153794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of expression of PSA, hK2, PSMA in the peripheral blood of patients with prostate cancer].
    Cui WG; Zhao H; Song YZ; Zhang J; Zhang LG; Shi JD; Qiang WM
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):479-81. PubMed ID: 15555338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.